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Objectives
The Oxford hip score (OHS) is a 12-item questionnaire designed and developed to assess 
function and pain from the perspective of patients who are undergoing total hip 
replacement (THR). The OHS has been shown to be consistent, reliable, valid and sensitive to 
clinical change following THR. It has been translated into different languages, but no 
adequately translated, adapted and validated Danish language version exists.
Methods
The OHS was translated and cross-culturally adapted into Danish from the original English 
version, using methods based on best-practice guidelines. The translation was tested for 
psychometric quality in patients drawn from a cohort from the Danish Hip Arthroplasty 
Register (DHR).
Results
The Danish OHS had a response rate of 87.4%, no floor effect and a 19.9% ceiling effect (as 
expected in post-operative patients). Only 1.2% of patients had too many items missing to 
calculate a sum score. Construct validity was adequate and 80% of our predefined hypotheses 
regarding the correlation between scores on the Danish OHS and the other questionnaires were 
confirmed. The intraclass correlation (ICC) of the different items ranged from 0.80 to 0.95 and the 
average limits of agreement (LOA) ranged from -0.05 to 0.06. The Danish OHS had a high internal 
consistency with a Cronbach’s alpha of 0.99 and an average inter-item correlation of 0.88.
Conclusions
This Danish version of the OHS is a valid and reliable patient-reported outcome measurement 
instrument (PROM) with similar qualities to the original English language version. 
Article focus
 The use of patient-reported outcome
measurement instruments (PROMs) in
orthopaedics is increasing
 Their development is laborious and costly
and therefore translation, cross-cultural
adaptation and validation of established
outcome measures is sensible and also
facilitates international comparisons
 To date, no validated version of the
Oxford hip score (OHS) has existed in the
Danish language
Key messages
 The Danish language version of the OHS
proved to be a valid PROM with similar
qualities to the original English language
version
Strengths and limitations
 This large validation study, which included
1992 post-operative patients, followed the
principles of best practice for the transla-
tion and cultural adaptation process for
PROMs and validated the Danish language
version of the OHS against several fre-
quently used generic (EuroQol 5D-3L (EQ-
5D) and Short-Form 12 (SF-12)) and dis-
ease-specific (Hip dysfunction and Osteo-
arthritis Outcome Score (HOOS)) PROMs
in the context of a hip arthroplasty registry
 The inclusion of patients from 30 to
80 years of age increases the external
validity of the psychometric findings, as
did measuring PROMs at one to two, five
to six and ten to 11 years following total
hip replacement
Freely available online
Keywords: Patient-reported outcome measurement instrument, PRO, PROMs, Oxford hip score, OHS, Validation, Total hip replacement, 
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 We included solely post-operative patients and further
studies on the responsiveness/sensitivity of the Danish
language version of the OHS are warranted. Patients
received two disease-specific questionnaires: they
answered the HOOS at a median post-operative time
period of 4.9 years (0.9 to 10.5) and the OHS at a median
of 7.1 years (3.1 to 12.8). Presumably both PROMs mea-
sured the patient’s health status during a period in
which their hip function was in the same steady state.
We did not exclude patients who had undergone
revision surgery or THR of the contralateral hip
Introduction
Total hip replacement (THR) – ‘the operation of the cen-
tury’1 – is a successful orthopaedic procedure with
respect to survival of the implant.1-5 Implant survival and
surgeon-reported outcomes have traditionally been used
to evaluate success. However, not everyone who has a
failing arthroplasty is willing or able to go through with
revision surgery. The recent shift towards a more patient-
centric perspective has led to a change of focus from tra-
ditional clinical outcomes to patient-reported outcomes,
which has revealed a much higher proportion of opera-
tions with inferior outcomes.6,7 By using patient-reported
outcomes the results of THR can be monitored to an
entirely different degree, potentially leading to improve-
ments in the treatment of these patients.
The Oxford hip score (OHS)8 is a frequently used
patient-reported outcome measurement instrument
(PROM) developed for patients undergoing THR. How-
ever, no adequately translated and culturally adapted
Danish version of the score exists. We aimed to develop
such a version for use in the Danish Hip Arthroplasty
Register (DHR).
Materials and Methods
The study was performed in two phases. In 2009, the
original OHS was translated into Danish and cross-
culturally adapted. Secondly, in 2011, following imple-
mentation of the Danish version, data from that version
were tested for psychometric quality.
OHS. The OHS is a short, 12-item questionnaire for
patients undergoing THR.8 It was designed as an inter-
vention- and site-specific outcome measure to assess
functional ability, daily activities and pain from the
patient’s perspective. Items are answered by ticking a box
on a five-point Likert scale. Originally, the raw scores were
added to obtain a sum score between 12 and 60, with
higher scores being better. Due to modifications, the sum
score is now described as ranging from 0 (worst) to
48 (best).9,10 The OHS has been translated into different
languages and used in several clinical studies and registry
settings. It has been shown to be consistent, reliable, valid
and sensitive to clinical change following THR.11-18
Thresholds in the OHS associated with patient satisfaction
with post-surgical outcomes have been estimated.19 A
license for the study and translation was obtained from
Isis Innovation (Oxford, United Kingdom).
Procedure for translation and cross-cultural adaptation.
The translation and cross-cultural adaptation process for
the OHS was carried out in accordance with a recom-
mended best-practice methodology,20 and involved the
following steps:
1. An uninformed forward-translation from English to
Danish (by translator T1, Associate Professor in English
Language in Denmark (mother tongue Danish, fluent in
English).
2. An uninformed back-translation from Danish to English
(by translator T2, Associate Professor in English Language in
Denmark (mother tongue English, fluent in Danish). 
3. An expert panel consensus meeting, during which
the original and back-translated English versions were
compared, and clinical/linguistic issues in the Danish for-
ward-translated version were resolved.
4. Five new individually uninformed back-translations
from Danish to English (by five members of a multidisci-
plinary group that included professional translators and
experienced health professionals; two with English as
their mother tongue, three with Danish as their mother
tongue, and all bilingual).
5. A new expert panel consensus meeting with transla-
tors and coordinators, where the versions were reviewed,
reconciled and harmonised, and the back-translations
compared with the original English version and prior
translations. This resulted in consensus on the Danish ver-
sion of the OHS.
6. The final Danish language version was tested for
understanding on 24 patients (ten men and 14 women)
with a mean age of 65 years (24 to 86), with hip dysfunc-
tion, hip osteoarthritis or THR, by experienced health pro-
fessionals. After completing the OHS, the respondents
were systematically interviewed and debriefed on their
thoughts concerning the relevance of the questions, the
specific wording of each item, any difficulties in under-
standing the questions, the readability, and their experi-
ence in answering the questionnaire. The interviewing
health professionals also assessed the patient’s ability to
complete the PROM, using the same criteria.
7. We used the PROMs in their standard lay-out, and
based on the testing, we made minimal adjustments to
optimise readability for elderly patients, and to facilitate
automated forms processing. Written instructions for the
PROM were added, layout, font, text size and points in cor-
respondences were adjusted after consulting typo-
graphers and educationalists, and these final modifications
were incorporated after examination of the outcomes from
the debriefing. The Danish language version of the OHS
was proofread by a key in-country consultant and project
manager, and a report prepared of the translation process.
Data collection. We used a cross-sectional design. Our
study was a secondary analysis of data from a previous
study of a cohort of 5777 patients from the Danish Hip
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Registry.21 The patients had received a primary THR either
one to two, five to six, or ten to 11 years before dispatch of
the PROMs. Patients who had revision surgery, or
received contralateral THR following the index operation,
were not excluded from the study. For the current study,
we included the subgroup of all patients between the
ages of 30 and 80 years who had answered the OHS.
These patients, as part of the original cohort, had
received one generic PROM, either the EuroQol 5D-3L
(EQ-5D)22 or Short-Form 12 (SF-12),23 and one disease-
specific PROM, either the Hip dysfunction and Osteo-
arthritis Outcome Score (HOOS)24 or the OHS.8 We also
included 215 patients who had previously answered the
HOOS. These patients were asked to also complete the
OHS to enable comparison of disease-specific PROMs.
They were randomly selected from the original cohort,
and received the OHS at two years after completing the
HOOS. This gave us a total of 2278 patients for the cur-
rent study. For test-retest validation, 212 patients received
the OHS twice within two weeks, at a median of 7.1 years
(3.1 to 12.8) after their index operation (Fig. 1). We
assumed the patients to be in the same state regarding
their hip when answering the questionnaires.
We included between 187 and 907 patients for each
combination of PROMs to calculate construct validity and
internal consistency, and 166 patients completed the test-
retest. These numbers are all higher than the recom-
mended minimum proposed by Terwee et al.25 All
PROMs were posted to the patients with a return-
addressed and stamped envelope. Paper questionnaire
formats were used, and up to two reminder letters were
sent.26 All returned PROMs were scanned electronically,
2278 patients were sent invitations (100%)
OHS & HOOS
215
OHS & SF-12
1032
OHS & EQ-5D
1031
OHS
212 sent retest
(3 patients declined
participation)
OHS
166 accepted and
participated in
retest (78%)
286 non-responders
(13%)
1992 patients accepted participation and were included (87%)
OHS & HOOS
187
OHS & SF-12
907
OHS & EQ-5D
898
Fig. 1
Flow chart showing participation (OHS, Oxford hip score; HOOS, Hip dysfunction
and Osteoarthritis Outcome Score; SF-12, Short-Form 12; EQ-5D, EuroQol 5D-3L).
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using a validated automated forms processing tech-
nique.27 The study was conducted in accordance with the
STROBE statement.28
Other PROMs. As a part of the validation, the Danish OHS
was compared with two generic outcome measures (EQ-
5D and SF-12) and a disease-specific outcome measure
(HOOS).
The EQ-5D is a standardised generic measure of health
outcome.22,29 The EQ-5D gives a summary index (EQ-5D
Index) and a VAS score (EQ-VAS). Its psychometric prop-
erties have been validated for THR30 and for patients with
rheumatoid arthritis.31 A license for the study was
obtained from The EuroQol Group.32
The SF-12 is a short form of the SF-36 with 12 items,23,33
a generic measure of health status. The SF-12 gives a
physical component summary score (PCS) and a mental
component summary score (MCS). Its psychometric
properties have been validated for osteoarthritis
patients.34 A license for the study was obtained from The
Medical Outcomes Trust Health Assessment Lab and
Quality Metric Incorporated.35
The HOOS includes five subscales: pain, other symp-
toms, function in daily living, function in sport and recre-
ation, and hip-related quality of life.24 The HOOS-Physical
Function Short form (HOOS PS) is a five-item short form of
the two HOOS subscales: function in daily living and sport
and recreation function. The HOOS PS has been validated
for THR.36 We used the HOOS subscales Pain (HOOS Pain),
HOOS PS and Hip-related Quality of Life (HOOS QoL).37
Psychometric properties. The Danish OHS was exam-
ined for response rate, floor and ceiling effects, skew of
the distribution, missing items, construct validity, reliabil-
ity (intraclass correlation, limits of agreement and inter
item correlation reliability), and internal consistency. We
defined response rate as the percentage of patients who
agreed to participate and answer the questionnaire, miss-
ing items as the percentage of all questionnaires with too
many items missing to calculate a sum score, as recom-
mended,10 floor and ceiling effects as the percentage of
patients at the extreme ends of the PRO (no possibility to
measure a meaningful deterioration of, or improvement
in, their condition), calculated as the percentages of
patients with the lowest (0) or highest (48) possible sum
score out of the total number of patients. Construct valid-
ity was tested by comparing the Spearman’s correlation
coefficients of the OHS scores with the domains of the
HOOS, EQ-5D, and SF-12. We hypothesised that the OHS
should have moderate to high (0.50 to 0.80) correlations
with HOOS Pain, HOOS PS and HOOS QoL; the pain/ dis-
comfort domain, mobility, current state of health and the
usual activities domain from the EQ-5D; and the general
health, physical component score and body pain
domains from the SF-12, since these domains are similar
to those of the OHS. We also hypothesised that the OHS
should show lower (< 0.50) correlations with the anxiety/
depression and self-care domains of the EQ-5D, and the
mental component score, vitality and social functioning
domains from the SF-12, since these domains are not
directly a part of the OHS. Reliability was measured as the
intraclass correlation coefficients (ICC), and the limits of
agreement (LOA). The time period between the repeated
administrations was 2 weeks. Internal consistency was
determined by calculating Cronbach’s Alpha38 for the
OHS. A value for Cronbach’s Alpha > 0.8 was considered
“good” while a value ≥ 0.9 was considered “excellent”.39
We used COSMIN definitions and taxonomy to describe
psychometric properties.40
Statistical analysis. Descriptive statistics were used to
describe patient characteristics. Response rate, floor and
ceiling effects, and missing items were calculated as pro-
portions with 95% confidence intervals (CI). We used a
chi-squared test to compare proportions. A p-value
< 0.05 was considered significant. For test-retest, we used
the STATA ‘sample’ command to draw random samples of
the original cohort from the Danish Hip Registry. Con-
struct validity was tested by comparing the Spearman’s
correlation coefficients. Internal consistency was deter-
mined by calculating Cronbach’s Alpha. Intraclass corre-
lation (ICC) was calculated as ICC[2,1] with STATA ‘icc23’
command (two-way random effects model). Bland and
Altman’s limits of agreement were calculated by STATA
‘concord’ command. The STATA software Version 11.0
(StataCorp LP, College Station, Texas) was used for all sta-
tistical analyses.
Ethics. The study was approved by the Danish Data Pro-
tection Agency (number 2008-41-2593), the Danish
National Board of Health, and DHR. The study was pre-
sented for the Science Ethics Committee of the Region of
Southern Denmark. They declared that the study did not
require acceptance from the committee due to no inter-
vention or human material were included. All patients
gave informed written consent and the study was carried
out in accordance with the Declaration of Helsinki.
Results
Patients. Patient characteristics are listed in Table I, and
their mean scores for PROMs are listed in Table II. Non-
responders were predominantly younger patients and
had the diagnoses ‘low impact fractures’ and ‘other
arthritis’ more often than responders. The mean OHS
score was 40. Post-operative follow-up was a median of
4.9 years (0.9 to 10.5).
Translation and cross-cultural adaptation. The transla-
tion process revealed minor discrepancies in wording and
comprehension for items 1 (Usual level of hip pain),
8 (Pain on standing up from sitting), 9 (Limping when
walking), 11 (Work interference due to pain), 12 (Pain in
bed at night) and option 4 in item 6 (Walking time before
severe pain), so these were rephrased in the translation
process. Some patients had problems with item 3 (Trou-
ble with transport), which was resolved by adding a writ-
ten instruction for the questionnaire.
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Psychometric properties. The OHS had a response rate
of 87.4%, no floor effect and 19.9% ceiling effect in our
post-operative patients. The frequency distribution of the
scores was negatively skewed (Fig. 2), with a skew value
of -1.39. Only 1% of patients had too many items missing
to calculate a sum score (Table III). Regarding construct
validity, OHS showed the highest correlations with the
HOOS Pain, HOOS PS and HOOS QoL; the pain/discom-
fort domain, mobility, current state of health and the
usual activities domain from the EQ-5D; and the body
pain domain from the SF-12 (rho = ±0.51 to 0.62)
(Table IV, V and VI). The OHS showed the lowest correla-
tions with the anxiety/depression and self-care domains
of the EQ-5D; and the mental component score, vitality
and social functioning domains from SF-12 (rho = ±0.32
Table I. Patient characteristics of responders and non-responders
Responders Non-responders p-value (chi-squared test)
Number (%) 1992 (87.4) 286 (12.6)
Female (n, %) 1088 (54.6) 165 (57.7) 0.329
Median age (yrs) (range)* 68.8 (31 to 80) 66.9 (32 to 80) 0.004 (Student’s t-test)
Age group (n, %)
30 to 49 years 138 (6.9)  35 (12.2) 0.002
50 to 70 years 955 (47.9) 133 (46.5) 0.649
71 to 80 years 899 (45.1) 118 (41.3) 0.218
Diagnosis (n, %)†‡
Idiopathic osteoarthritis 1598 (80.6) 186 (65.3) < 0.001
Low-impact fractures  116 (5.9)  38 (13.3) < 0.001
Childhood diseases  113 (5.7)  16 (5.6) 0.953
Other arthritis  53 (2.7)  18 (6.3) 0.001
High-impact injuries  20 (1.0)  3 (1.1) 0.945
Atraumatic necrosis of femoral head  62 (3.1)  17 (6.0) 0.015
Other  20 (1.0)  7 (2.5) 0.035
Prostheses design (n, %)‡
Uncemented 1091 (55.0) 154 (54.0) 0.749
Cemented  433 (21.8)  63 (22.1) 0.921
Hybrid  458 (23.1)  68 (23.9) 0.779
* age of patients on date of dispatch of the patient-reported outcome measures 
† other arthritis (including rheumatoid arthritis, Bechterew’s disease), childhood diseases (congenital hip dislocation,
Calvé-Legg-Perthes, epiphysiolysis, acetabular dysplasia), high-impact injuries (fracture of acetabulum, traumatic hip
dislocation) and low-impact fractures (fresh fracture of proximal femur, late sequel from fracture of proximal femur) 
‡ data on diagnosis and prosthesis design was only available for 1982 responders and 285 non-responders
Table II. Scores of the patient-reported outcome
measures (PROMs) for the total population (CI,
confidence interval)
PROM Mean (95% CI)
OHS (n = 1992)* 39.8 (39.3 to 40.2)
HOOS (n = 187)†
Pain 91.4 (89.3 to 93.5)
Physical function 86.7 (84.2 to 89.3)
Hip-related quality of life 82.1 (79.2 to 85.0)
SF-12 (n = 907)‡
Physical component 38.5 (38.2 to 38.8)
Mental component 46.8 (46.5 to 47.2)
EuroQol 5D-3L (n = 898)§
EQ-5D Index 0.85 (0.84 to 0.86)
EQ-VAS 79.7 (78.3 to 81.1)
* OHS, Oxford hip score (from 0 (worst) to
48 (best)) 
† HOOS, Hip dysfunction and Osteoarthritis
Outcome Score (from 0 (worst) to 100 (best)) 
‡ SF-12, Short-Form 12 (from 0 (worst) to
100 (best), by computation with a standardised
scoring algorithm developed to get a mean of
50 (SD 10) in the United States 1998 general popu-
lation value set
§ EuroQol 5D-3L. The EQ-5D Index ranges from -0.624
(worst) to 1.000 (best), using a Danish value set.45
EQ-VAS, visual analogue scale for current state of
health (from 0 (worst) to 100 (best))
OHS
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Fig. 2
Bar chart showing the skew of distribution of the Oxford hip score (OHS).
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to 0.46). SF-12 general health, body pain domain and
physical component score had a correlation of 0.38 to
0.49. Thus 12 of the 15 predefined hypotheses about the
strength of correlation were confirmed. The test-retest
reliability of the OHS sum score was established with an
ICC of 0.96 (95% CI 0.94 to 0.97), and limits of agree-
ment was -0.05 (95% CI -4.67 to 4.58) (Table VII). For
internal consistency, the overall Cronbach’s alpha was
0.99, and the average inter-item correlation was 0.88
(Table VIII).
Discussion
PROMs are an important addition to measuring implant sur-
vival, and essential for patient perspectives of outcome.41,42
Table IV. Construct validity: Spearman’s correlation coefficient between the
Oxford hip score (OHS) and the Hip dysfunction and Osteoarthritis Outcome Score
(HOOS)
HOOS
n = 177 OHS Pain Physical function Quality of life
OHS 1.00
HOOS
Pain 0.53* 1.00
Physical function 0.51* 0.75* 1.00
Quality of life 0.51* 0.72* 0.22* 1.00
* statistically significant (p ≤ 0.05)
Table V. Construct validity: Spearman’s correlation coefficient between the Oxford hip score (OHS) and the EuroQol 5D-3L
(EQ-5D)
EQ-5D
n = 941 OHS Mobility Self-care
Usual 
activities
Pain/
discomfort
Anxiety/
depression
Current state
of health
OHS 1.00
EQ-5D
Mobility -0.56* 1.00
Self-care -0.44*  0.47* 1.00
Usual activities -0.61  0.62*  0.44* 1.00
Pain/discomfort -0.62*  0.62*  0.40*  0.61* 1.00
Anxiety/depression -0.32*  0.34*  0.31*  0.36*  0.37* 1.00
Current state of health  0.61* -0.54* -0.39* -0.59* -0.59* -0.37* 1.00
* statistically significant (p ≤ 0.05)
Table III. Response rate, floor effect, ceiling effect and missing items of the Oxford hip score (OHS) compared with the Hip dysfunction and Osteoarthritis
Outcome Score (HOOS), Short-Form 12 (SF-12) and EuroQol 5D-3L (EQ-5D)
HOOS (n = 187) SF-12 (n = 907) EQ-5D (n = 898)
OHS
(n = 1992) Pain
Physical
function
Quality 
of life
Physical 
component
Mental 
component Index VAS
Response rate* 87.4 
(86.1 to 88.8)
87.0 (82.4 to 91.58) 87.9 (85.9 to 89.9) 87.1 (85.1 to 89.1)
p-value Reference 0.843 0.782 0.721
Floor effect† 0.0 0.0 0.0 0.0 0.1 
(-0.1 to 0.3)
0.1
(-0.1 to 0.3)
0.0 0.1 
(-0.1 to 0.3)
p-value Reference - - - 0.138 0.138 - 0.136
Ceiling effect‡ 19.9 
(18.1 to 21.6)
46.0 
(38.8 to 53.2)
39.6
(32.5 to 46.6)
30.0
(23.3 to 36.6)
8.3 
(6.5 to 10.1)
8.3 
(6.5 to 10.1)
49.9 
(46.6 to 53.2)
12.0 
(9.9 to 14.2)
p-value Reference < 0.001 < 0.001 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Missing items§ 1.2 
(0.7 to 1.6)
2.1 
(0.5 to 4.2)
2.1 
(0.5 to 4.2)
0.5
(-0.5 to 1.6)
0.8 
(0.2 to 1.3)
0.8 
(0.2 to 1.3)
1.0 
(0.3 to 1.7)
4.2 
(2.9 to 5.6)
p-value Reference 0.245 0.245 0.437 0.345 0.345 0.717 < 0.001
* defined as percentage who accepted participation and answered the patient-reported outcome measures out of total number. No subscale calculations
† ﬂoor effect deﬁned as percentage of worst possible outcome out of total number 
‡ ceiling effect deﬁned as percentage of best possible outcome out of total number 
§ too many items missing to calculate a sum score (if more than 2 items were omitted, the response was considered invalid and no overall score was calcu-
lated, in accordance with the User Manual)
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We translated and cross-culturally adapted the OHS into
Danish, and the subsequent validation showed similar psy-
chometric properties to the original OHS.
This translation of the OHS into Danish used a robust
methodology that maximised linguistic accuracy and
cross-cultural adaptation. There were only minor discrep-
ancies concerning wording and understanding in the
translation process, probably due to the relatively small
cultural differences between the United Kingdom and
Denmark. In item 6 instead of the original option 4,
“around the house only”, we chose to focus on walking
distance (“only very short distances”) because of differ-
ences in the size and the number of floors in homes in
Denmark compared with the United Kingdom.
Table VI. Construct validity: Spearman’s correlation coefficient between the Oxford hip score (OHS) and the Short-Form 12
(SF-12)
SF-12
n = 380 OHS
Physical
component
Mental 
component Vitality
Body
pain
Social 
functioning
General
health
OHS 1.00
SF-12
PCS 0.39* 1.00
MCS 0.46* 0.30* 1.00
Vitality 0.37 0.57* 0.66* 1.00
Body pain 0.49* 0.78* 0.53* 0.56* 1.00
Social functioning 0.38* 0.36* 0.76* 0.46* 0.46* 1.00
General health 0.38* 0.73* 0.50* 0.60* 0.66* 0.41* 1.00
* statistically significant (p ≤ 0.05)
Table VII. Intraclass correlation (ICC) and limits of agreement (LOA) of the Oxford hip score (OHS)
Question Content* ICC (95% CI) Average LOA (95% CI)
1 Usual level of hip pain 0.87 (0.83 to 0.91) -0.02 (-1.05 to 1.01)
2 Trouble with washing and drying 0.85 (0.80 to 0.89)  0.01 (-0.71 to 0.72)
3 Trouble with transport 0.81 (0.74 to 0.85) -0.02 (-0.94 to 0.91)
4 Putting on socks/stockings/tights 0.85 (0.80 to 0.88)  0.06 (-0.86 to 0.99)
5 Doing household shopping alone 0.95 (0.93 to 0.96) -0.01 (-0.51 to 0.48)
6 Walking time before severe pain 0.80 (0.73 to 0.85) -0.01 (-1.10 to 1.09)
7 Difficulty going up stairs 0.84 (0.79 to 0.88) -0.05 (-0.96 to 0.86)
8 Pain on standing up from sitting 0.83 (0.77 to 0.87)  0.00 (-0.89 to 0.89)
9 Limping when walking 0.81 (0.75 to 0.85)  0.06 (-0.94 to 1.07)
10 Sudden, severe pain from hip 0.86 (0.82 to 0.90)  0.04 (-0.79 to 0.88)
11 Work interference due to pain 0.85 (0.80 to 0.88) -0.02 (-0.95 to 0.91)
12 Pain in bed at night 0.86 (0.81 to 0.89) -0.01 (-0.91 to 0.89)
OHS sum score 0.96 (0.94 to 0.97) -0.05 (-4.67 to 4.58)
* the wording of each item reported in this table is in abridged form
Table VIII. Internal consistency of the Oxford hip score. The mean inter-item correlation is 0.88 and the overall Cronbach’s
alpha is 0.99
Question Content* Obs.
Mean (SE) 
score
Item total 
correlation
Alpha if item
removed
1 Usual level of hip pain 1980 3.55 (0.04) 0.94 0.93
2 Trouble with washing and drying 1988 3.90 (0.03) 0.95 0.94
3 Trouble with transport 1989 3.77 (0.04) 0.95 0.94
4 Putting on socks/stockings/tights 1988 3.63 (0.04) 0.93 0.91
5 Doing household shopping alone 1978 3.93 (0.04) 0.94 0.93
6 Walking time before severe pain 1986 3.84 (0.04) 0.94 0.93
7 Difficulty going up stairs 1963 3.71 (0.04) 0.95 0.94
8 Pain on standing up from sitting 1973 3.78 (0.04) 0.96 0.95
9 Limping when walking 1969 3.61 (0.04) 0.91 0.89
10 Sudden, severe pain from hip 1969 3.76 (0.04) 0.94 0.92
11 Work interference due to pain 1968 3.64 (0.04) 0.97 0.96
12 Pain in bed at night 1975 3.74 (0.04) 0.93 0.91
* the wording of each item reported in this table is in abridged form
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Item 3 is complex and comprises three different ques-
tions: “Have you had any trouble getting in a car because
of your hip?”, “Have you had any trouble getting out of a
car because of your hip?” and “Have you had any trouble
using public transport because of your hip?”. The testing
showed that some patients were unsure of how to
answer, if they answered yes to only one or two of these
questions. To resolve this problem, we added Danish
written instructions to the OHS, as an addendum.
The OHS had an excellent response rate of 87%. We
consider a response rate of 80% as being sufficiently
representative of the sample studied. We found no floor
effect but a ceiling effect that was beyond the recom-
mended 15% ceiling. Others have found a similar ceiling
effect for the OHS.25,43,44 Since the current results could
be explained by the median post-operative follow-up
period of five years in our study and the good overall
clinical outcome from THR,43 it could be argued that the
finding is merely a degree of skew, which is to be
expected given the timing of measures relative to the
intervention, and this can explain the skew in sum score
distribution. Consistent with this, Naal et al18 found a
lower ceiling effect with the pre-operative OHS. In con-
trast, SF-12 PCS and SF-12 MCS had lower ceiling effects,
as reported by others and explained by computation of
a norm-based value set.31 Considering the good out-
come of THR, low floor effects and high ceiling effects
can be expected; therefore, the criterion of having the
best possible score in less than 15% of patients following
THR might be too restrictive.21 Concerning missing
items, the OHS performed similarly to the other PROMs
in our study. We have followed the instructions given in
the 2010 User Manual for the OHS10 for dealing with
missing data. However, imputed data can be problem-
atic to use for assessing the measurement properties of
an instrument, as imputed data will artificially reduce
variation in overall scores.
Convergent and divergent construct validity were ade-
quate with over 75% of the predefined hypotheses con-
firmed.25 de Groot et al44 also found a moderate to high
correlation between the OHS and the HOOS Pain (-0.85)
and HOOS QoL(-0.62). The correlation of the OHS with
the SF-36 has also been found to be moderate to high
(±0.53 to 0.71) for the physical function and bodily pain
domains in post-operative patients.10,17 
The Danish OHS translation was found to have accept-
able test-retest reliability, with an ICC > 0.70.25 The ICC of
the different items ranged from 0.80 to 0.95, and the OHS
sum score had a LOA of -0.05 (-4.67 to 4.58) and an ICC of
0.96 (0.94 to 0.97), which is better than the original OHS
and other language versions.10,16,18 This might be
explained by the post-operative administration of the
OHS in our study. 
Internal consistency of the OHS was found to be very
high as expected, with a Cronbach’s alpha of 0.99. A
Cronbach’s alpha over 0.95 could be explained by a
possible redundancy in one or more items.25 Cronbach’s
alphas of 0.87 to 0.89 have been reported in preoperative
patients,17,18 0.89 at six months post-operatively,8,13 and
0.93 to 0.92 at one to two years post-operatively,13 and
seems to rise directly in line with the length of follow-up.
We therefore believe the very high alpha found is almost
certainly due to the long follow-up period, where
patients are likely to have few or no symptoms giving a
suboptimal timeframe to assess the Cronbach’s alpha,
and not due to item redundancy – in the usual sense of
the term.
We found an excellent response rate. We included a
wide age range of patients from 30 to 80 years; most
patients undergo THR in this age range. Our study popu-
lation is slightly younger than the Danish THR popula-
tion, but we believe that our results have high external
validity since the gender ratio and diagnoses are similar
between our study population and the Danish THR pop-
ulation. The Danish OHS was validated in the context of a
registry of hip replacements, compared with both generic
and disease-specific PROMs, and examined at one to two,
five to six, and ten to 11 years following THR.
Several methodological limitations have to be taken
into consideration when interpreting our results. This is
a secondary data analysis and we have solely included
post-operative patients. The psychometric properties of
PROMs used in elective surgical contexts are usually
largely evaluated on pre-operative data, making the
interpretation of our ceiling effect, skew and internal
consistency more demanding. Since the patients are all
post-operative, we expected the OHS to be highly
skewed, and it could therefore be argued that referring
to ceiling effects could be misleading. We argue that it is
important to assess post-operative development, and
have chosen to report the percentage of ceiling at PROM
level, even though this characteristic would more often
be assessed at the individual item level in the develop-
ment of a PROM. Further studies on the responsiveness/
sensitivity to the Danish version of the OHS are war-
ranted. Patients who received two disease-specific
PROMs answered the HOOS at a median of 4.9 years
(0.9 to 10.5) post-operatively and the OHS at a median
of 7.1 years (3.1 to 12.8) post-operatively, when both
PROMs presumably measured the patient’s health status
during a period in which their hip function was in the
same steady state. We did not exclude patients who had
undergone revision surgery, or received contralateral
THR following the index operation
The Danish version of the OHS had good feasibility, an
excellent response rate, no floor effect, but a high ceiling
effect as was expected with our post-operative patients,
and few patients missed too many items to calculate a
sum score. The Danish version of the OHS is a valid and
reliable tool for outcome studies on THR patients, in com-
parison with the HOOS, EQ-5D and SF-12, and can be
used in a hip registry setting.
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Supplementary material
The Danish version of the Oxford hip score with
instructions is available alongside this article at
www.bjr.boneandjoint.org.uk
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Sådan udfyldes Oxford Hofte Score (OHS): 
 
 
 
• Læs teksten/ vejledningen på spørgeskemaet. 
 
 
• Du skal svare på alle spørgsmål i forhold til, hvad der bedst 
beskriver, hvordan du har haft det i løbet af de sidste fire 
uger. 
 
 
• Hvis der er spørgsmål, hvor dit svar ikke helt passer til 
svarmulighederne, skal du sætte kryds ved det svar, der 
passer bedst til din situation.  
 
 
• Der skal kun sættes ét kryds per spørgsmål. 
 
 
• Det er vigtigt for undersøgelsen, at alle spørgsmålene 
besvares.  
 
 
• Det er vigtigt at bruge en kuglepen der skriver mørkeblåt eller 
anden mørk farve, når skemaet udfyldes. 
 
 
• Kryds skal være nemme at tolke, som vist i nedenstående 
eksempler. 
 
 
Eksempler på angivelser af 
afkrydsning 
 
RIGTIGT FORKERT 
 
Sæt tydeligt kryds indenfor feltet. 
Kryds må ikke ramme kanten rundt 
om feltet 
   
 
Hvis et felt er udfyldt forkert, skal 
HELE feltet skraveres, og krydset 
sættes i det rigtige felt. 
  
  
 
X 
X X 
X
      ¥ ¥ 
      ¥       1                                                                ¥
 
Oxford Hofte Score (OHS), Dansk version, marts 2009. 
 
CPR. NR: 
 
N år du ser tilbage på de sidste fire uger …  (Kun ét kryds per spørgsmål) 
1. 
Ingen 
smerter 
2. 
Meget lette 
smerter 
3. 
Lette 
smerter 
4. 
Moderate 
smerter 
5. 
Stærke 
smerter 
 
1. Hvordan vil du 
beskrive de 
smerter, som du 
har haft i hoften?      
 
1. 
Nej, slet 
ingen 
problemer 
2. 
Meget lidt 
besvær 
3. 
Ja, 
moderat 
besvær 
4. 
Ja, meget 
store  
problemer 
5. 
Det er 
helt 
umuligt 
 
2. Har du haft 
problemer med at 
vaske og tørre dig 
(over det hele)  
på grund af         
din hofte?      
 
1. 
Nej, ingen 
problemer 
2. 
Meget lidt 
besvær 
3. 
Ja, 
moderat 
besvær 
4. 
Ja, meget 
store 
problemer 
5. 
Det er 
helt 
umuligt 
 
3. Har du haft 
problemer med at 
komme ind i eller 
ud af en bil eller 
bruge offentlig 
transport på 
grund af hoften? 
 
     
 
1. 
Ja, 
nemt 
2. 
Næsten 
uden 
besvær 
3. 
Med 
moderat 
besvær 
4. 
Med meget
stort  
besvær 
5. 
Nej, 
umuligt 
 
4. Har du selv 
kunnet tage 
sokker, strømper 
eller strømpe-
bukser på?      
 
1. 
Ja, 
nemt 
2. 
Næsten 
uden 
besvær 
3. 
Med 
moderat 
besvær 
4. 
Med meget
stort  
besvær 
5. 
Nej, det 
har været  
umuligt 
 
5. Har du selv 
kunnet klare 
indkøb? 
     
 
1. 
Ingen 
smerter/ 
jeg kan gå 
mere end 
30 
minutter 
2. 
16 til 30 
minutter 
3. 
5 til 15 
minutter 
4. 
Kun meget 
korte 
afstande 
 
5. 
Det er 
helt 
umuligt at 
gå 
 
6. Hvor lang tid  
har du kunnet gå,   
før du har fået    
stærke smerter  
i hoften (med   
eller uden stok)? 
      
 
      ¥ ¥ 
      ¥       2                                                                ¥
 
Når du ser tilbage på de sidste fire uger …  (Kun ét kryds per spørgsmål) 
  
1. 
Ja, 
nemt 
2. 
Næsten 
uden 
besvær 
3. 
Med 
moderat 
besvær 
4. 
Med meget
stort  
besvær 
5. 
Nej, det 
har været 
umuligt 
 
7. Har du kunnet gå 
op ad trapper? 
     
 
1. 
Slet ingen 
smerter 
2. 
Lette 
smerter 
3. 
Moderate 
smerter 
4. 
Stærke 
smerter 
5. 
Uudholdelige 
smerter 
 
8. Hvor stærke 
smerter har du 
haft i hoften, når 
du har skullet 
rejse dig op efter 
at have siddet ned 
(f.eks. ved 
middagsbordet)? 
     
 
1. 
Sjældent / 
aldrig 
2. 
Somme-
tider eller 
kun når 
jeg 
begynder 
at gå 
3. 
Ja, en hel 
del, og 
ikke kun 
når jeg 
begynder 
at gå 
4. 
Ja, 
det meste 
af tiden 
5. 
Ja, 
hele tiden 
 
9. Har du haltet  
på grund af  
din hofte? 
     
 
1. 
Nej, ikke 
på noget 
tidspunkt 
 
2. 
Kun en 
enkelt dag 
eller to 
3. 
Nogle 
dage 
4. 
De fleste 
dage 
5. 
Hver 
dag 
 
10. Har du følt 
pludselig eller 
kraftig smerte 
(jagende, 
stikkende eller 
krampe-lignende) 
fra den dårlige 
hofte?      
 
1. 
Slet ikke 
2. 
En lille 
smule 
3. 
En del 
4. 
Meget 
5. 
Umuligt at 
arbejde 
 
11. I hvor høj grad 
har smerter  
i hoften    
besværliggjort  
dit sædvanlige     
arbejde (inkl.    
husarbejde)? 
     
  1. 
Nej, ikke 
på noget 
tidspunkt 
2. 
Kun en 
enkelt nat 
eller to 
3. 
Nogle 
nætter 
4. 
De fleste 
nætter 
5. 
Hver 
nat 
 
12. Har du været 
plaget af smerter  
i hoften, når du 
ligger i sengen  
om natten?      
 
